Sponsor:
PedAL BCU, LLC
Code:
NCT05183035
Conditions
Acute Myeloid Leukemia
Eligibility Criteria
Sex: All
Age: 0 - 21
Healthy Volunteers: Not accepted
Interventions
Fludarabine
Cytarabine
Gemtuzumab Ozogamicin
Azacitidine
Venetoclax
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-08. This information was provided to ClinicalTrials.gov by PedAL BCU, LLC on 2025-10-15.